目的 探讨参苓控瘤方对结直肠腺瘤术后患者临床疗效及肠道菌群的调节作用。 方法 选取62例结直肠腺瘤术后患者,随机分为观察组(n=31,服用参苓控瘤方,疗程3个月)和对照组(n=31,标准随访)。术后1年复查肠镜。观察指标包括中医证候评分及疗效、复发率、血清炎症因子(IL-6、TNF-α)水平、肠屏障功能(DAO、D-LA)水平及肠道菌群组成。采用SPSS 26.0进行统计分析。 结果 观察组中医证候总分及复发率(12.90%,4/31)显著低于对照组(35.48%,11/31)(PPP 结论 参苓控瘤方可有效降低结直肠腺瘤术后复发率,改善临床症状,并通过调节肠道菌群改善炎症及肠屏障功能,为结直肠腺瘤术后防治提供新策略。
Building similarity graph...
Analyzing shared references across papers
Loading...
Jincheng WANG
Rui PAN
Lilu Bai
Building similarity graph...
Analyzing shared references across papers
Loading...
WANG et al. (Sun,) studied this question.
www.synapsesocial.com/papers/69ba427c4e9516ffd37a2c5a — DOI: https://doi.org/10.70976/j.1008-0805.szgygy-2026-0314
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: